Matches in Wikidata for { <http://www.wikidata.org/entity/Q66073956> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q66073956 description "clinical trial" @default.
- Q66073956 description "ensayu clínicu" @default.
- Q66073956 description "klinisch onderzoek" @default.
- Q66073956 description "клінічне випробування" @default.
- Q66073956 name "Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults" @default.
- Q66073956 name "Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus" @default.
- Q66073956 type Item @default.
- Q66073956 label "Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults" @default.
- Q66073956 label "Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus" @default.
- Q66073956 prefLabel "Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults" @default.
- Q66073956 prefLabel "Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus" @default.
- Q66073956 P1132 Q66073956-7493C724-AC65-415D-A61B-2536920A06EE @default.
- Q66073956 P1476 Q66073956-1EEA0403-193A-4584-AB1F-F4372B9FAE39 @default.
- Q66073956 P17 Q66073956-0D395FA9-67D1-4271-AC17-E8B4E2F6DCC6 @default.
- Q66073956 P17 Q66073956-A2A9743B-A706-4387-8AF8-42D64BFF8CF2 @default.
- Q66073956 P2899 Q66073956-35D4908F-7FED-48DE-90AF-200BD825B01E @default.
- Q66073956 P3098 Q66073956-AD98659A-BB79-4CBE-ADA6-9458B19EA25B @default.
- Q66073956 P31 Q66073956-52F9BF24-AED5-4701-99AD-BEE10442AA84 @default.
- Q66073956 P4135 Q66073956-95A63D74-56F0-473E-B641-9C88BF92FA61 @default.
- Q66073956 P580 Q66073956-107B3476-2699-4545-85F7-32BB8460C396 @default.
- Q66073956 P582 Q66073956-AED187F0-2C19-48B5-9C61-1F1CA2DF3BCB @default.
- Q66073956 P6099 Q66073956-95E51ECB-026A-4DAA-B3E6-1ADD98CB2DE5 @default.
- Q66073956 P6153 Q66073956-DAD09880-4259-4710-B731-B744BA2E2CE1 @default.
- Q66073956 P8363 Q66073956-F538C4A1-DA7B-43B0-A0C5-4C00D66B60D8 @default.
- Q66073956 P859 Q66073956-C257E6F7-6E42-4E0A-930F-0CACF0EEF7A7 @default.
- Q66073956 P1132 "+33" @default.
- Q66073956 P1476 "A Phase 2a, Multicenter, Randomized, Adaptive, Open-label, Dose Ranging Study to Evaluate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of Cobicistat-boosted GSK2838232 Monotherapy Over 10 Days in HIV-1 Infected Treatment-naive Adults" @default.
- Q66073956 P17 Q16 @default.
- Q66073956 P17 Q30 @default.
- Q66073956 P2899 "+18" @default.
- Q66073956 P3098 "NCT03045861" @default.
- Q66073956 P31 Q30612 @default.
- Q66073956 P4135 "+55" @default.
- Q66073956 P580 "2017-03-17T00:00:00Z" @default.
- Q66073956 P582 "2018-04-23T00:00:00Z" @default.
- Q66073956 P6099 Q42824440 @default.
- Q66073956 P6153 Q212322 @default.
- Q66073956 P8363 Q78089383 @default.
- Q66073956 P859 Q212322 @default.